The heart of clinical practice is the patient. In this series, we speak with both providers and patients about the clinical journey with a neurologic condition, and what recent advances mean for patients, their providers, and caregivers.
Bill Nye on Ataxia, Family Risk, and the Search for Answers
In this episode, Bill Nye—science communicator, television presenter, and ataxia advocate—shares his experience growing up in a family affected by ataxia, discusses the challenges of individuals living with rare neurologic diseases, and reflects on how he has been impacted by the knowledge of his own risk. He is joined by Lauren Moore, PhD, Vice President of Research and Chief Scientific Officer of the National Ataxia Foundation, Golden Valley, MN, who discusses common barriers to diagnosis, clinical management strategies, educational resources for neurologists, and the evolving ataxia treatment landscape.
8 May 2026
The Power of Movement for Parkinson Disease
Dr. Nina Mosier, MD, an Internal Medicine physician specializing in Geriatric Medicine, shares the journey of her father after his diagnosis with Parkinson Disease. She also discusses the importance of movement in these patients and describes Power for Parkinson's, the movement organization for she co-founded and serves as executive director.Resources: https://www.powerforparkinsons.org/https://www.youtube.com/@PowerforParkinsons
30 Jan 2026
Living with Spinal Muscular Atrophy: Genetic Testing, Therapy, and More
Andrew Cherico, a student at the University of Central Florida, Orlando, FL, discusses his experience living with spinal muscular atrophy (SMA), the impacts of available treatments, and how the condition intersects with his passion for sports journalism. He is joined by John W. Day, MD, PhD, Professor of Neurology and Pediatrics, Director, Division of Neuromuscular Medicine at Stanford University School of Medicine, and Co-Director of Stanford’s Neuro IGNITE Center, Stanford, CA, who describes the importance of genetic testing, the landscape of available SMA treatments, and the significance of the newly approved one-time gene therapy Itvisma (onasemnogene abeparvovec-brve; Novartis, East Hanover, NJ).
Podcast Authority Score: 7 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
2
Social presence
0
YouTube
0
Engagement
27
Contact Amplifying the Patient Journey
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Amplifying the Patient Journey?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
